Di Zhou

914 total citations
40 papers, 682 citations indexed

About

Di Zhou is a scholar working on Surgery, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Di Zhou has authored 40 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Biomedical Engineering and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Di Zhou's work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Nanoplatforms for cancer theranostics (8 papers) and Photoacoustic and Ultrasonic Imaging (6 papers). Di Zhou is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Nanoplatforms for cancer theranostics (8 papers) and Photoacoustic and Ultrasonic Imaging (6 papers). Di Zhou collaborates with scholars based in China, Canada and United States. Di Zhou's co-authors include Zhiwei Quan, Mingzhe Weng, Shouhua Wang, Yongjie Zhang, Jiandong Wang, Mingzhe Ma, Qiang Cai, Zhigang Wang, Wei Gong and Ershun Pan and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and Molecular Cancer.

In The Last Decade

Di Zhou

39 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Di Zhou China 13 266 187 184 180 163 40 682
Min Dong China 13 149 0.6× 147 0.8× 66 0.4× 115 0.6× 116 0.7× 33 562
Min En Nga Singapore 13 198 0.7× 256 1.4× 270 1.5× 48 0.3× 131 0.8× 36 895
Chenchen Wang China 16 275 1.0× 67 0.4× 166 0.9× 185 1.0× 179 1.1× 68 821
Wending Huang China 19 220 0.8× 196 1.0× 293 1.6× 162 0.9× 310 1.9× 48 1.1k
Jae Jun Park South Korea 13 87 0.3× 116 0.6× 165 0.9× 39 0.2× 117 0.7× 48 660
Kouichi Asano Japan 10 160 0.6× 60 0.3× 275 1.5× 87 0.5× 207 1.3× 20 789
Min Bai China 17 146 0.5× 271 1.4× 133 0.7× 109 0.6× 87 0.5× 37 698
Xiaona Lin China 14 105 0.4× 117 0.6× 83 0.5× 86 0.5× 122 0.7× 50 794
Jiafei Chen China 16 338 1.3× 69 0.4× 109 0.6× 161 0.9× 109 0.7× 37 689

Countries citing papers authored by Di Zhou

Since Specialization
Citations

This map shows the geographic impact of Di Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Zhou more than expected).

Fields of papers citing papers by Di Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Zhou. The network helps show where Di Zhou may publish in the future.

Co-authorship network of co-authors of Di Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Di Zhou. A scholar is included among the top collaborators of Di Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Zhou. Di Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sun, Yuxin, Xiaoxuan Li, Shouhua Wang, et al.. (2023). Drug resistance and new therapies in gallbladder cancer. Drug Discoveries & Therapeutics. 17(4). 220–229. 6 indexed citations
3.
Han, Nannan, Di Zhou, Min Ruan, Ming Yan, & Chenping Zhang. (2023). Cancer cell-derived extracellular vesicles drive pre-metastatic niche formation of lymph node via IFNGR1/JAK1/STAT1-activated-PD-L1 expression on FRCs in head and neck cancer. Oral Oncology. 145. 106524–106524. 9 indexed citations
4.
Zhou, Di, Ershun Pan, & Yimin Zhang. (2021). Fractional polynomial function in stochastic response surface method for reliability analysis. Journal of Mechanical Science and Technology. 35(1). 121–131. 10 indexed citations
5.
Wang, Shouhua, Tingting Su, Di Zhou, et al.. (2021). Circβ-catenin promotes tumor growth and Warburg effect of gallbladder cancer by regulating STMN1 expression. Cell Death Discovery. 7(1). 233–233. 11 indexed citations
6.
Sun, Yuxin, Di Zhou, Shouhua Wang, Jun Ding, & Fei Ma. (2021). Updated genetic studies of Marfan syndrome in China. Intractable & Rare Diseases Research. 10(4). 288–291. 2 indexed citations
7.
Wang, Shouhua, et al.. (2021). CircTP63 promotes cell proliferation and invasion by regulating EZH2 via sponging miR-217 in gallbladder cancer. Cancer Cell International. 21(1). 608–608. 14 indexed citations
8.
Zhang, Liang, et al.. (2021). NIR Laser Responsive Nanoparticles for Ovarian Cancer Targeted Combination Therapy with Dual-Modal Imaging Guidance. International Journal of Nanomedicine. Volume 16. 4351–4369. 11 indexed citations
9.
Zhou, Di, Yufan Zhang, Chunfu Zhang, et al.. (2020). NIR/photoacoustic imaging of multitype gallbladder cancer using carboxyl/amino functionalized polymer dots. Biomaterials Science. 8(23). 6657–6669. 3 indexed citations
10.
Zhang, Mingdi, Chunxiao Wu, Bin Zuo, et al.. (2020). Trends of gallbladder cancer incidence, mortality, and diagnostic approach in urban Shanghai between 1973 and 2009. Tumori Journal. 106(5). 392–399. 7 indexed citations
11.
Wang, Shouhua, Yongjie Zhang, Qiang Cai, et al.. (2019). Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression. Molecular Cancer. 18(1). 145–145. 149 indexed citations
12.
Zhou, Di, Jiandong Wang, Zhiwei Quan, Yong Yang, & Fei Ma. (2019). Improvement in the diagnosis and treatment of T2 gallbladder carcinoma is pivotal to improvement in the overall prognosis for this disease. BioScience Trends. 13(1). 1–9. 5 indexed citations
13.
Zhang, Mingdi, Shizhong Cai, Bin Zuo, et al.. (2017). Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway. Tumor Biology. 39(5). 3726131435–3726131435. 27 indexed citations
14.
Zhou, Di, Chuanfei Li, Minyu He, et al.. (2016). Folate-targeted perfluorohexane nanoparticles carrying bismuth sulfide for use in US/CT dual-mode imaging and synergistic high-intensity focused ultrasound ablation of cervical cancer. Journal of Materials Chemistry B. 4(23). 4164–4181. 37 indexed citations
15.
Zhou, Di, Jiandong Wang, Yong Yang, et al.. (2016). Individualized nomogram improves diagnostic accuracy of stage I-II gallbladder cancer in chronic cholecystitis patients with gallbladder wall thickening. Hepatobiliary & pancreatic diseases international. 15(2). 180–188. 11 indexed citations
17.
Zhou, Di, et al.. (2014). Laparoscopic-Assisted Versus Open Distal Gastrectomy with D2 Lymph Node Resection for Advanced Gastric Cancer: Effect of Learning Curve on Short-Term Outcomes. A Meta-analysis. Journal of Laparoendoscopic & Advanced Surgical Techniques. 24(3). 139–150. 37 indexed citations
18.
Zhou, Di, Wenbin Guan, Jiandong Wang, et al.. (2013). A Comparative Study of Clinicopathological Features between Chronic Cholecystitis Patients with and without Helicobacter pylori Infection in Gallbladder Mucosa. PLoS ONE. 8(7). e70265–e70265. 27 indexed citations
19.
Zhou, Di, Jiandong Wang, Mingzhe Weng, et al.. (2012). Infections of Helicobacter spp. in the biliary system are associated with biliary tract cancer. European Journal of Gastroenterology & Hepatology. 25(4). 447–454. 53 indexed citations
20.
Zhou, Di, Yong Zhang, Wei Gong, et al.. (2011). Are Helicobacter Pylori and Other Helicobacter Species Infection Associated with Human Biliary Lithiasis? A Meta-Analysis. PLoS ONE. 6(11). e27390–e27390. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026